Drug Channels

AUGUST 23, 2022

on key specialty pharmacy trends Evidence for biosimilar-to-biosimilar switching Plus, Dr. Glaucomflecken takes on PBMs! P.S. Join my more than 31,000 LinkedIn followers for daily links to neat stuff. You can also find my daily posts at @DrugChannels on Twitter , where I have more than 15,000 followers.

Biosimilars 98

Biosimilars Specialty Pharmacies Pharmacy Drugs 98

Drug Channels

APRIL 27, 2021

While we all roll up our sleeves for a full reopening, let’s spring into this month’s selection of noteworthy news: Thoughts on Cigna’s payments to patients for non-medical switching 340B’s explosive specialty pharmacy growth An excellent analysis of GoodRx Plus, my $0.02 drug pricing policy. 3, and more.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Biosimilars Drugs 52

Drug Channels

NOVEMBER 23, 2021

In this issue: The State of Specialty Pharmacy 2021 How health plans profit—and patients lose—from insulin A fantastic new analysis of the gross-to-net bubble CVS acknowledges how its PBM profits from 340B Reconsidering Amazon P.S. You can also find my daily posts on LinkedIn , where I have more than 21,000 followers.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Biosimilars Drugs 52

Drug Channels

JUNE 5, 2023

View the Agenda Snapshot Enhance Patient Service, Network Design, and Channel Strategies to Improve Patient Access and Support In its 8th year, the Specialty Network and Patient Support Services Summit is an important event for senior leaders in patient access, trade, channel, market access, brand and account strategy.

Specialty Pharmacies 74

Specialty Pharmacies Pharmacy Biosimilars Compliance 74

Drug Channels

MAY 27, 2020

Before you venture outside for your lockdown barbeque, check out these noteworthy items off the Drug Channels grill: Payers predict how COVID-19 will affect formularies Our analysis of the 2020 retail-to-mail shift AmerisourceBergen profiles biosimilars Plus, CVS pharmacy offers a clever way to measure appropriate social distancing.

Biosimilars 52

Biosimilars Specialty Pharmacies Pharmacy Hospitals 52

Drug Channels

NOVEMBER 9, 2022

During the event, Dr. Fein will share his latest thinking on a wide range of topics, including: Retail and specialty pharmacy trends Vertical integration and consolidation The Inflation Reduction Act of 2022 The Medicare Part D Redesign Biosimilars Discount cards and cash-pay pharmacies The growing impact of hospitals and health systems The 340B Drug (..)

Specialty Pharmacies 98

Specialty Pharmacies Pharmacy Biosimilars Drugs 98

Drug Channels

NOVEMBER 24, 2020

In this issue: Rebate rule redux Most Favored Nation and healthcare benchmarking Amazon’s pharmacy customer opportunity Drug spending realities updated GPO consolidation Plus, I congratulate Dirk Rodgers of RxTrace on his retirement. Before you stretch your stomach, stretch your mind with this extra-stuffed helping of food for thought.

Pharmacy 52

Pharmacy Specialty Pharmacies Biosimilars Doctors 52

Drug Channels

NOVEMBER 8, 2021

Join your industry counterparts this December to unravel the complexities of the channel, navigate high-impact topics transforming trade and benchmark winning pharmacy and distribution frameworks. Drug Channels readers will save 10% off the current registration rate when they use promo code 10DC21*. Meet The Expert Faculty.

Specialty Pharmacies 75

Specialty Pharmacies Pharmacy Biosimilars Marketing 75

Drug Channels

OCTOBER 10, 2023

Drug Distribution Industry Gaining from Anti-Obesity Drugs and Provider-Administered Biosimilars (press release) We’re offering special discounted pricing if you order before October 20, 2023! reviews the evolving specialty pharmacy industry and discusses emerging challenges from direct distribution models that bypass wholesale distribution.

Pharmaceuticals 40

Pharmaceuticals Specialty Pharmacies Pharmacy Biosimilars 40

Drug Channels

NOVEMBER 15, 2021

PLUS: During the webinar, Dr. Fein will give participants an opportunity to unmute themselves and ask live questions.

Specialty Pharmacies 94

Specialty Pharmacies Biosimilars Pharmacy Drugs 94